| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.095 | 0.1 |